πŸ‡ΊπŸ‡Έ FDA
Patent

US 7358085

Anti-angiogenic methods and compositions

granted A61KA61K38/00A61P

Quick answer

US patent 7358085 (Anti-angiogenic methods and compositions) held by Sangamo Biosciences, Inc. expires Mon Apr 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sangamo Biosciences, Inc.
Grant date
Tue Apr 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K38/00, A61P, A61P27/02, A61P35/00